McKesson Corporation ($MCK) continues to garner interest from a rapidly expanding pool of investors, as detailed in recent reports. Strategic stock purchases, persistently strong earnings in Q3, and a price target boost facilitated by Barclays indicate an upward momentum for the company within the market. Various institutional investors, such as
Quantbot Technologies, are increasing their share holdings in McKesson. Amid financial activities, McKesson reported strong fiscal 2026 Q3 returns and revised its full year adjusted EPS guidance, pushing its shares to a new 12-month high. The performance has invited a 'Moderate Buy' rating from brokerages, and opinion pieces predict a strong growth trajectory for McKesson in the healthcare sector. However, fluctuations occur as certain companies trimmed their positions, and the stock witnessed a 5.2% dip after the last earnings report. Nevertheless,
BofA maintains its bullish view, citing the company's robust third-quarter performance. The ongoing stock purchases and the company's ability to defy political influences also contribute to its appeal, as discussed in Wall Street assessments.
Mckesson Corporation MCK News Analytics from Wed, 25 Jun 2025 00:09:22 GMT to Sat, 28 Feb 2026 14:11:37 GMT -
Rating 7
- Innovation 3
- Information 6
- Rumor -3
